[en] The current invention concerns peptides capable of binding to LDL-receptor, wherein said peptide has at least 90% sequence identity to an amino acid sequence chosen from SEQ ID 1 to 12, and it concerns peptides capable of binding to LDL-receptor, wherein said peptide has an amino acid sequence that differs maximally two amino acids from SEQ ID 1 to 12, as well as conjugate compounds comprising such peptides, as well as the use of such peptides in compositions.
Research center :
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale
